Autoimmune protein S activity deficiency following a Q fever

• References

• 1 Song KS, Park YS, Kim HK. Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 2000; 43: 557-560.
• 2 Guermazi S, Regnault V, Gorgi Y. et al. Further evidence for the presence of anti-protein Sautoantibodies in patients with systemic lupus erythematosus. Blood Coagul Fibrinolysis 2000; 11: 491-498.
• 3 Bertolaccini ML, Sanna G, Ralhan S. et al. Anti-bodies directed to proteinS in patients with systemic lupus erythematosus: prevalence and clinical significance. Thromb Haemost 2003; 90: 636-641.
• 4 D’Angelo A, Della Valle P, Crippa L. et al. Auto-immuneprotein Sdeficiency in a boy with severe thromboembolic disease. N Engl J Med 1993; 328: 1753-1757.
• 5 Levin M, Eley BS, Louis J. et al. Postinfectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr 1995; 127: 355-363.
• 6 Manco-Johnson MJ, Nuss R, Key N. et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996; 128: 319-323.
• 7 Peyvandi F, Faioni E, Alessandro Moroni G. et al. Autoimmune protein S deficiency and deep vein thrombosis after chickenpox. Thromb Haemost 1996; 75: 212-213.
• 8 van Ommen CH, van Wijnen M, de Groot FG. et al. Postvaricella purpura fulminans caused by acquired proteins deficiency resulting from anti-protein S anti-bodies: search for the epitopes. J Pediatr Hematol Oncol 2002; 24: 413-416.
• 9 Regnault V, Boehlen F, Ozsahin H. et al. Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation. J Thromb Haemost 2005; 3: 1243-1249.
• 10 Bergmann F, Hoyer PF, D’Angelo SV. et al. Severe autoimmune protein S deficiency in a boy with idiopathic purpura fulminans. Br J Haematol 1995; 89: 610-614.
• 11 Sorice M, Griggi T, Circella A. et al. Protein S anti-bodies in acquired proteinSdeficiencies. Blood 1994; 83: 2383-2384.
• 12 Roussel V, Yi F, Jauberteau MO. et al. Prevalence and clinical significance of antiphospholipid anti-bodies in multiple sclerosis: a study of 89 patients. J Autoimmun 2000; 14: 259-265.
• 13 Ordi-Ros J, Selva-O’Callaghan A, Monegal-Ferran F. et al. Prevalence, significance, and specificity of antibodies to phospholipids in Q fever. Clin Infect Dis 1994; 18: 213-218.
• 14 Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999; 12: 518-553.
• 15 Nojima J, Kuratsune H, Suehisa E. et al. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 2001; 47: 1008-1015.
• 16 Fernandez Guerrero ML, Rivas P, Garcia Delgado R. Migratory thrombophlebitis and acute Q fever. Emerg Infect Dis 2004; 10: 546-547.
• 17 Galvez J, Martin I, Merino D. et al. Thrombophlebitis in a patient with acute Q fever and anticardiolipin antibodies. Med Clin (Barc) 1997; 108: 396-397.
• 18 del Arco A, de La Torre J, Luis Prada J. et al. Pulmonary embolism in a patient with Q fever. Are the anticardiolipin antibodies the origin? Enferm Infecc Microbiol Clin 2001; 19: 137-138.
• 19 Vidal M, Corbin V, Chanet V. et al. Infections associated to severe thrombotic events and antiphospholipid antibodies. Med Mal Infect 2005; 35: 552-555.
• 20 Philip RN, Casper EA, Ormsbee RA. et al. Micro-immunofluorescence test for the serological study of rocky mountain spotted fever and typhus. J Clin Microbiol 1976; 3: 51-61.